Drug dosage intensity — a panel discussion William L McGuireJames GoldieDouglass C Tormey Viewpoints Pages: 87 - 100
Nuclear DNA content and prognosis in human breast cancer: A static cytophotometric study Jennet HarveyNicholas de KlerkJohn Papadimitriou Report Pages: 101 - 109
Biological differences among MCF-7 human breast cancer cell lines from different laboratories C. Kent OsborneKimberly HobbsJeffrey M. Trent Report Pages: 111 - 121
Progesterone binding cyst protein (PBCP) in primary breast cancer: A new prognostic factor? Jon Arne SøreideOscar A. LeaStener Kvinnsland Report Pages: 123 - 128
Oestrogen receptor activity in intraduct and invasive breast carcinomas R. A. HawkinsA. L. TesdaleJ. J. Going Report Pages: 129 - 133
Social and biological factors in relation to survival among black vs. white women with breast cancer Barbara ValanisJohn WirmanVicki Stover Hertzberg Report Pages: 135 - 143
Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand Raewyn K. McNeeBarbara H. MasonRonald G. Kay Report Pages: 145 - 150
Estrogenic effects of phenolphthalein on human breast cancer cellsin vitro Peter Marcus RavdinMarc van BeurdenV. Craig Jordan Brief communication Pages: 151 - 154
Retrovirus association with breast cancer: A critical appraisal Arnold S. Dion Meeting report Pages: 155 - 156
Long-term adjuvant tamoxifen study: Clinical update Douglass C. TormeyP. RasmussenV. Craig Jordan Correspondence Pages: 157 - 158